Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1326714-87-7

Post Buying Request

1326714-87-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-3-carbonitrile

    Cas No: 1326714-87-7

  • No Data

  • No Data

  • No Data

  • Debye Scientific
  • Contact Supplier

1326714-87-7 Usage

General Description

1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-3-carbonitrile is a chemical compound with a complex molecular structure. It contains a tetrahydro-2H-pyran-2-yl group, a 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group, and a 1H-indazole-3-carbonitrile group. 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-3-carbonitrile has potential applications in pharmaceutical research and drug development due to its unique structure and potential biological activity. It may be used as a building block in the synthesis of new chemical compounds with specific properties, and its structure suggests potential use as a drug candidate or as a reference standard in analytical chemistry. Further research and testing are needed to fully understand the properties and potential uses of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1326714-87-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,2,6,7,1 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1326714-87:
(9*1)+(8*3)+(7*2)+(6*6)+(5*7)+(4*1)+(3*4)+(2*8)+(1*7)=157
157 % 10 = 7
So 1326714-87-7 is a valid CAS Registry Number.

1326714-87-7Downstream Products

1326714-87-7Relevant articles and documents

7-AMINOFUROPYRIDINE DERIVATIVES

-

, (2011/09/15)

Compounds of Formula 1, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by TAK1 or for which an appropriate TAK1 inhibitor is effective. This Abstract is not limiting of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1326714-87-7